NO20041845L - Fremgangsmate for a reagere alkaloider og anvendelse av reaksjonsprodukter i fremstillingen av medikamenter - Google Patents

Fremgangsmate for a reagere alkaloider og anvendelse av reaksjonsprodukter i fremstillingen av medikamenter

Info

Publication number
NO20041845L
NO20041845L NO20041845A NO20041845A NO20041845L NO 20041845 L NO20041845 L NO 20041845L NO 20041845 A NO20041845 A NO 20041845A NO 20041845 A NO20041845 A NO 20041845A NO 20041845 L NO20041845 L NO 20041845L
Authority
NO
Norway
Prior art keywords
medicaments
manufacture
reaction products
alkaloids
reacting
Prior art date
Application number
NO20041845A
Other languages
English (en)
Other versions
NO334701B1 (no
NO20041845D0 (no
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of NO20041845D0 publication Critical patent/NO20041845D0/no
Publication of NO20041845L publication Critical patent/NO20041845L/no
Publication of NO334701B1 publication Critical patent/NO334701B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G5/00Alkaloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/564Three-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • C07F9/65846Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20041845A 2001-11-15 2004-05-05 Fremgangsmåte for å reagere alkaloider og anvendelse av reaksjonsprodukter i fremstillingen av medikamenter NO334701B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH02094/01A CH695417A5 (de) 2001-11-15 2001-11-15 Verfahren zur Umsetzung von Alkaloiden.
PCT/EP2002/012003 WO2003041721A1 (en) 2001-11-15 2002-10-28 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments

Publications (3)

Publication Number Publication Date
NO20041845D0 NO20041845D0 (no) 2004-05-05
NO20041845L true NO20041845L (no) 2004-06-25
NO334701B1 NO334701B1 (no) 2014-05-12

Family

ID=4567486

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041845A NO334701B1 (no) 2001-11-15 2004-05-05 Fremgangsmåte for å reagere alkaloider og anvendelse av reaksjonsprodukter i fremstillingen av medikamenter

Country Status (38)

Country Link
US (1) US20050043340A1 (no)
EP (1) EP1443943B1 (no)
JP (1) JP2005509006A (no)
KR (1) KR100849488B1 (no)
CN (1) CN100436462C (no)
AR (1) AR037527A1 (no)
AT (1) ATE485826T1 (no)
AU (1) AU2002346888B2 (no)
BR (1) BR0214173A (no)
CA (1) CA2465723C (no)
CH (1) CH695417A5 (no)
CO (1) CO5580784A2 (no)
CR (1) CR7340A (no)
CU (1) CU23451B7 (no)
CY (1) CY1111139T1 (no)
DE (1) DE60238134D1 (no)
DK (1) DK1443943T3 (no)
EA (1) EA007097B1 (no)
EC (1) ECSP045107A (no)
ES (1) ES2353207T3 (no)
GE (1) GEP20053701B (no)
HR (1) HRP20040430A2 (no)
HU (1) HU229688B1 (no)
IL (2) IL161766A0 (no)
IS (1) IS2812B (no)
MA (1) MA26232A1 (no)
MX (1) MXPA04004643A (no)
NO (1) NO334701B1 (no)
NZ (1) NZ532941A (no)
PL (1) PL212111B1 (no)
PT (1) PT1443943E (no)
RS (1) RS51219B (no)
SA (1) SA02230496B1 (no)
TN (1) TNSN04084A1 (no)
TW (1) TWI262080B (no)
UA (1) UA76535C2 (no)
WO (1) WO2003041721A1 (no)
ZA (1) ZA200403371B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
WO2006053680A1 (en) * 2004-11-19 2006-05-26 Nowicky Wassili Ex vivo cancer diagnostic method
WO2006053649A1 (en) * 2004-11-19 2006-05-26 Nowicky Wassili Method for the detection of cancer
WO2007073919A2 (en) 2005-12-28 2007-07-05 Nowicky Wassili Method and kit for the detection of cancer
ITMI20080284A1 (it) * 2008-02-22 2009-08-23 Indena Spa Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
CA2941315C (en) * 2016-08-12 2018-03-06 Api Labs Inc. High thebaine poppy and methods of producing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865830A (en) * 1969-06-16 1975-02-11 Nikolai Mikhailovich Turkevich Thiophosphamide derivatives of isoquinoline alkaloids, method of producing and application thereof
SU368254A1 (ru) * 1969-06-16 1973-01-26 А. И. Потопальский , В. М. Новицкий Львовский государственный медицинский институт Способ получения соединений тиофосфамида с алкалоидами чистотела большого
AT354644B (de) * 1975-12-19 1980-01-25 Nowicky Wassili Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure
AT377988B (de) * 1976-06-28 1985-05-28 Nowicky Wassili Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
AT407608B (de) * 1994-03-18 2001-05-25 Nowicky Wassili Mittel zur behandlung von osteoporose
AT407833B (de) * 1995-06-01 2001-06-25 Nowicky Wassyl Dr Mittel zur behandlung von strahlenschäden
AT408719B (de) * 2000-03-22 2002-02-25 Nowicky Wassili Mittel zur behandlung von hepatitis c

Also Published As

Publication number Publication date
CA2465723A1 (en) 2003-05-22
HRP20040430A2 (en) 2004-08-31
CR7340A (es) 2004-12-06
MA26232A1 (fr) 2004-07-01
EP1443943B1 (en) 2010-10-27
PL212111B1 (pl) 2012-08-31
HUP0402365A2 (hu) 2005-02-28
US20050043340A1 (en) 2005-02-24
ZA200403371B (en) 2005-05-04
PT1443943E (pt) 2010-12-03
EA007097B1 (ru) 2006-06-30
NO334701B1 (no) 2014-05-12
RS40804A (sr) 2006-12-15
CN100436462C (zh) 2008-11-26
GEP20053701B (en) 2005-12-12
IL161766A0 (en) 2005-11-20
CA2465723C (en) 2010-01-05
PL368879A1 (en) 2005-04-04
AU2002346888B2 (en) 2007-03-22
CH695417A5 (de) 2006-05-15
UA76535C2 (en) 2006-08-15
CY1111139T1 (el) 2015-06-11
CN1422859A (zh) 2003-06-11
AR037527A1 (es) 2004-11-17
ATE485826T1 (de) 2010-11-15
KR100849488B1 (ko) 2008-07-31
DE60238134D1 (de) 2010-12-09
DK1443943T3 (da) 2011-02-14
AU2002346888C1 (en) 2003-05-26
IS2812B (is) 2012-11-15
TNSN04084A1 (en) 2006-06-01
JP2005509006A (ja) 2005-04-07
NO20041845D0 (no) 2004-05-05
IL161766A (en) 2009-11-18
IS7245A (is) 2004-04-30
HK1054041A1 (zh) 2003-11-14
TWI262080B (en) 2006-09-21
RS51219B (sr) 2010-12-31
KR20050040859A (ko) 2005-05-03
SA02230496B1 (ar) 2008-09-10
MXPA04004643A (es) 2005-03-14
EP1443943A1 (en) 2004-08-11
HRP20040430B1 (no) 2012-11-30
EA200400679A1 (ru) 2004-10-28
ES2353207T3 (es) 2011-02-28
WO2003041721A1 (en) 2003-05-22
ECSP045107A (es) 2004-06-28
BR0214173A (pt) 2004-09-28
CO5580784A2 (es) 2005-11-30
CU23451B7 (es) 2009-10-16
HU229688B1 (en) 2014-04-28
NZ532941A (en) 2006-08-31

Similar Documents

Publication Publication Date Title
IL166058A0 (en) Novel thiophenylglycoside derivatives methods for production thereof medicaments comprising said compounds and use thereof
IL166747A0 (en) Water-soluble iron-carbohydrate complexes production thereof and medicaments containing said complexes
IL173271A (en) Affected derivatives of h1-pyrazole-3-carboxylic acid conserved in position 4, a process for preparing and using them to produce the drug
NO20031694D0 (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
NO20023408L (no) Substrater inneholdende polymerer av koblede sandwich koordinasjonsforbindelser og fremgangsmåte for anvendelse derav
NO20035696D0 (no) Krystallinsk anti-cholinergikum, fremgangsmåte for fremstilling derav og anvendelse derav til fremstilling av et legemiddel
NO20034079D0 (no) Fremgangsmåte for fremstilling av interpolymerer og produkter laget derav
NO20030341D0 (no) Skallmetallkatalysator og en forlöper for denne, en fremgangsmåte for fremstilling av disse og anvendelse av katalysatoren
SI1532149T1 (sl) amino piperidin il ksantini njihova priprava in njihova uporaba kot zdravila
IL196010A0 (en) Pyrazole derivatives and process for the production thereof
PT1448591E (pt) 17alfa-alquil-17beta-oxi-estratrieno e produtos intermediários para a sua preparação, utilização do 17alfaalquil-17beta-oxi-estratrieno para a preparação de medicamentos e preparações farmacêuticas
IL164292A (en) Quinoline and isoquinoline derivatives, method for the production thereof and use thereof in the manufacture of medicaments
IL166039A0 (en) New effector conjugates process for their production and their pharmaceutical use
IL165723A0 (en) Process for the production of precipitated calciumcarbonates and product produced thereby
NO20014809D0 (no) Kjemisk fremgangsmåte og produkt
NO20013880L (no) Matriks og fremgangsmåte for fremstilling av polyolefiner
EP1422522A4 (en) COLUMN TRIM AND CORRESPONDING PRODUCTION PROCESS
NO20041845L (no) Fremgangsmate for a reagere alkaloider og anvendelse av reaksjonsprodukter i fremstillingen av medikamenter
IL162509A (en) Use of deoxypeganine for the production of a drug for treating clinical depression
HUP0105345D0 (en) Amlodipine bezylate tablets having extended stability and process for producing the same
FI20010730A0 (fi) Menetelmä hoitotuotteen valmistamiseksi ja hoitotuote
HUP0302989A3 (en) Benzamidine derivatives and process for production thereof
DE60013638D1 (de) Oral anzuwendendes pharmazeutisches produkt und herstellungsverfahren
ZA200501648B (en) New effector conjugates, process for their production and their pharmaceutical use
AU2002346849A1 (en) Use of hydroxyoleic acid and similar compounds in the production of medicaments

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees